FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169169045> ?p ?o ?g. }

• W2169169045 endingPage "559" @default.
• W2169169045 startingPage "552" @default.
• W2169169045 abstract "Background. Chronic utilization of a bio-incompatible peritoneal dialysis (PD) solution with acidic pH and a high content of glucose degradation product (GDP) has been implicated as a contributing cause of peritoneal failure. We compared a newly formulated solution of neutral pH and low levels of GDP to a standard PD solution. Methods. Fifty new PD patients were randomized to a conventional lactate-buffered fluid (control) and a pH neutral, lactate-buffered, low GDP solution (balance). Patients were followed for 12 months. Serum samples were assayed for C-reactive protein (CRP). PD effluent was collected and assayed for cancer antigen-125 (CA125) and hyaluronan (HA). Clinical end points were the residual renal function and dialysis adequacy indices. Results. After 52 weeks of treatment, PD fluid CA125 rose from 2.45 ± 0.96 to 14.30 ± 2.17 U/ml (P < 0.001), and HA declined from 2.26 ± 0.60 to 1.45 ± 0.32 μg/ml (P = 0.07) in the balance group. The balance group had a higher PD fluid CA-125 (14.30 ± 2.17 vs 7.36 ± 2.23 U/ml, P = 0.007), lower HA (1.45 ± 0.32 vs 2.55 ± 0.32 μg/ml, P = 0.007), and lower serum CRP level (1.77 ± 0.42 vs 7.73 ± 2.42 mg/l, P = 0.026) than the control group at 52 weeks. There was no difference in dialysis adequacy indices, ultrafiltration volume, urine output, residual renal function, peritonitis rate or need of hospitalization in 1 year. Conclusion. As compared to conventional PD solution, the use of balance, a neutral pH, low GDP solution resulted in a superior profile of PDE mesothelial cell marker and a lower degree of systemic inflammation, and the difference was maintained for 1 year. It remains to be determined whether these effects could result in better long-term clinical outcome." @default.
• W2169169045 created "2016-06-24" @default.
• W2169169045 creator A5000398237 @default.
• W2169169045 creator A5006663907 @default.
• W2169169045 creator A5007190507 @default.
• W2169169045 creator A5053550425 @default.
• W2169169045 creator A5063429550 @default.
• W2169169045 creator A5070401295 @default.
• W2169169045 creator A5075902219 @default.
• W2169169045 creator A5086293217 @default.
• W2169169045 date "2006-09-02" @default.
• W2169169045 modified "2023-09-25" @default.
• W2169169045 title "Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--A 1-year randomized control trial" @default.
• W2169169045 cites W1894989396 @default.
• W2169169045 cites W1899442605 @default.
• W2169169045 cites W1971221852 @default.
• W2169169045 cites W1982470672 @default.
• W2169169045 cites W1990877999 @default.
• W2169169045 cites W1992554486 @default.
• W2169169045 cites W2001853431 @default.
• W2169169045 cites W2015111897 @default.
• W2169169045 cites W2045958359 @default.
• W2169169045 cites W2069504946 @default.
• W2169169045 cites W2072124048 @default.
• W2169169045 cites W2077338510 @default.
• W2169169045 cites W2084318392 @default.
• W2169169045 cites W2084929939 @default.
• W2169169045 cites W2092333610 @default.
• W2169169045 cites W2098854885 @default.
• W2169169045 cites W2105026045 @default.
• W2169169045 cites W2110855207 @default.
• W2169169045 cites W2111841549 @default.
• W2169169045 cites W2116281652 @default.
• W2169169045 cites W2118154631 @default.
• W2169169045 cites W2124029618 @default.
• W2169169045 cites W2133970329 @default.
• W2169169045 cites W2136465314 @default.
• W2169169045 cites W2139621019 @default.
• W2169169045 cites W2144601461 @default.
• W2169169045 cites W2148296794 @default.
• W2169169045 cites W2153281701 @default.
• W2169169045 cites W2156994754 @default.
• W2169169045 cites W2157196487 @default.
• W2169169045 cites W2168305895 @default.
• W2169169045 cites W2181319562 @default.
• W2169169045 cites W2181871794 @default.
• W2169169045 cites W2183055246 @default.
• W2169169045 cites W2346692818 @default.
• W2169169045 cites W2410316532 @default.
• W2169169045 cites W2410479401 @default.
• W2169169045 cites W2618993071 @default.
• W2169169045 doi "https://doi.org/10.1093/ndt/gfl559" @default.
• W2169169045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17005526" @default.
• W2169169045 hasPublicationYear "2006" @default.
• W2169169045 type Work @default.
• W2169169045 sameAs 2169169045 @default.
• W2169169045 citedByCount "160" @default.
• W2169169045 countsByYear W21691690452012 @default.
• W2169169045 countsByYear W21691690452013 @default.
• W2169169045 countsByYear W21691690452014 @default.
• W2169169045 countsByYear W21691690452015 @default.
• W2169169045 countsByYear W21691690452016 @default.
• W2169169045 countsByYear W21691690452017 @default.
• W2169169045 countsByYear W21691690452018 @default.
• W2169169045 countsByYear W21691690452019 @default.
• W2169169045 countsByYear W21691690452020 @default.
• W2169169045 countsByYear W21691690452021 @default.
• W2169169045 countsByYear W21691690452022 @default.
• W2169169045 countsByYear W21691690452023 @default.
• W2169169045 crossrefType "journal-article" @default.
• W2169169045 hasAuthorship W2169169045A5000398237 @default.
• W2169169045 hasAuthorship W2169169045A5006663907 @default.
• W2169169045 hasAuthorship W2169169045A5007190507 @default.
• W2169169045 hasAuthorship W2169169045A5053550425 @default.
• W2169169045 hasAuthorship W2169169045A5063429550 @default.
• W2169169045 hasAuthorship W2169169045A5070401295 @default.
• W2169169045 hasAuthorship W2169169045A5075902219 @default.
• W2169169045 hasAuthorship W2169169045A5086293217 @default.
• W2169169045 hasBestOaLocation W21691690451 @default.
• W2169169045 hasConcept C126322002 @default.
• W2169169045 hasConcept C126894567 @default.
• W2169169045 hasConcept C141071460 @default.
• W2169169045 hasConcept C159641895 @default.
• W2169169045 hasConcept C168563851 @default.
• W2169169045 hasConcept C2778063415 @default.
• W2169169045 hasConcept C2779056158 @default.
• W2169169045 hasConcept C2779978075 @default.
• W2169169045 hasConcept C2780199535 @default.
• W2169169045 hasConcept C2780306776 @default.
• W2169169045 hasConcept C71924100 @default.
• W2169169045 hasConcept C90924648 @default.
• W2169169045 hasConceptScore W2169169045C126322002 @default.
• W2169169045 hasConceptScore W2169169045C126894567 @default.
• W2169169045 hasConceptScore W2169169045C141071460 @default.
• W2169169045 hasConceptScore W2169169045C159641895 @default.
• W2169169045 hasConceptScore W2169169045C168563851 @default.
• W2169169045 hasConceptScore W2169169045C2778063415 @default.
• W2169169045 hasConceptScore W2169169045C2779056158 @default.

• next